775 453 453
sklep@napad.pl
No one read the comments.
Lena received the news via a terse email from the hospital's risk management office. She sat in her darkened office, the glow of her monitor painting her face blue. She pulled up the algorithm's source code—just 847 lines, most of them comments, apologies, caveats.
Word spread. Not through journals—Lena hadn't published yet—but through the quiet network of geneticists, cardiologists, and orthopedists who traded war stories over stale coffee at conferences. Someone uploaded a bootleg version to a hospital intranet. Someone else built a cleaner web interface.
Dr. Marcus Tse at St. Jude's ran the calculator on a 41-year-old woman with chronic joint pain and a history of miscarriages. Her score was —well below the threshold. He sighed with relief and sent her to rheumatology.
The boy was tall. His arms were long. He smiled, a little nervously, and asked, "Am I just built weird, or is something wrong?"
But the story became: The Marfan calculator missed a fatal case.
Below it, a sentence: "Elevated probability of systemic features. Recommend genetic sequencing for FBN1."